Cite
MLA Citation
Pedro M Folegatti et al.. “Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial.” Lancet infectious diseases, vol. 20, no. 7, 2020, pp. 816–826. http://access.bl.uk/ark:/81055/vdc_100104125699.0x000012